formylmethionyl-leucyl-phenylalanine methyl ester has been researched along with Alcoholic Cirrhosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Djerdjouri, B; El-Benna, J; Elkrief, L; Hadjoudj, S; Makhezer, N; Moreau, R; PĂ©rianin, A; Rolas, L | 1 |
1 other study(ies) available for formylmethionyl-leucyl-phenylalanine methyl ester and Alcoholic Cirrhosis
Article | Year |
---|---|
Inhibition of mammalian target of rapamycin aggravates the respiratory burst defect of neutrophils from decompensated patients with cirrhosis.
Topics: Antibiotics, Antineoplastic; Cytosol; Drug Interactions; Escherichia coli Infections; Female; HL-60 Cells; Humans; Liver Cirrhosis, Alcoholic; Male; MAP Kinase Signaling System; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; NADPH Oxidases; Neutrophils; p38 Mitogen-Activated Protein Kinases; Phagocytosis; Phosphorylation; Respiratory Burst; Sirolimus; TOR Serine-Threonine Kinases | 2013 |